xanax xr

Generic: alprazolam

Labeler: viatris specialty llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name xanax xr
Generic Name alprazolam
Labeler viatris specialty llc
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

alprazolam 3 mg/1

Manufacturer
Viatris Specialty LLC

Identifiers & Regulatory

Product NDC 58151-506
Product ID 58151-506_d8ad22b9-9ba3-4193-a678-23d5563d9511
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021434
DEA Schedule civ
Marketing Start 2024-07-26
Marketing End 2027-02-28

Pharmacologic Class

Established (EPC)
benzodiazepine [epc]
Chemical Structure
benzodiazepines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 58151506
Hyphenated Format 58151-506

Supplemental Identifiers

RxCUI
433798 433799 433800 433801 687022 687023 687024 687025
UPC
0358151506910 0358151504916 0358151503919 0358151505913
UNII
YU55MQ3IZY
NUI
N0000175694 M0002356

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name xanax xr (source: ndc)
Generic Name alprazolam (source: ndc)
Application Number NDA021434 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 3 mg/1
source: ndc
Packaging
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (58151-506-91)
source: ndc

Packages (1)

Ingredients (1)

alprazolam (3 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d8ad22b9-9ba3-4193-a678-23d5563d9511", "openfda": {"nui": ["N0000175694", "M0002356"], "upc": ["0358151506910", "0358151504916", "0358151503919", "0358151505913"], "unii": ["YU55MQ3IZY"], "rxcui": ["433798", "433799", "433800", "433801", "687022", "687023", "687024", "687025"], "spl_set_id": ["c8990714-c2f5-4b0c-9f1c-91d77156d962"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "manufacturer_name": ["Viatris Specialty LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (58151-506-91)", "package_ndc": "58151-506-91", "marketing_end_date": "20270228", "marketing_start_date": "20240726"}], "brand_name": "Xanax XR", "product_id": "58151-506_d8ad22b9-9ba3-4193-a678-23d5563d9511", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "58151-506", "dea_schedule": "CIV", "generic_name": "alprazolam", "labeler_name": "Viatris Specialty LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Xanax", "brand_name_suffix": "XR", "active_ingredients": [{"name": "ALPRAZOLAM", "strength": "3 mg/1"}], "application_number": "NDA021434", "marketing_category": "NDA", "marketing_end_date": "20270228", "marketing_start_date": "20240726"}